Total planned funding: $580,278,285
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $580,278,285 |
Organizational Types
NGO | $160,760,553 |
Private Contractor | $109,735,826 |
Host Country Government Agency | $98,214,699 |
Own Agency | $76,666,320 |
Unknown | $54,179,563 |
University | $49,708,093 |
Parastatal | $9,138,351 |
Other USG Agency | $8,166,132 |
Implementing Agency | $6,353,059 |
FBO | $4,915,689 |
Multi-lateral Agency | $2,440,000 |
Program Areas
Treatment | $156,081,285 |
Prevention | $123,151,946 |
Care | $114,026,640 |
Governance and Systems | $92,320,373 |
Management and Operations | $52,948,334 |
Testing | $41,749,707 |
Budget Codes
HTXS: Treatment: Adult Treatment | $127,546,173 |
HVMS: Management and Operations | $52,948,334 |
HKID: Care: Orphans and Vulnerable Children | $45,062,753 |
OHSS: Health Systems Strengthening | $44,975,301 |
HVCT: Testing: HIV Testing and Counseling | $41,749,707 |
HVOP: Sexual Prevention: Other Sexual Prevention | $37,863,874 |
HVSI: Strategic Information | $36,574,756 |
HBHC: Care: Adult Care and Support | $36,080,955 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $30,055,956 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $24,310,067 |
HVTB: Care: TB/HIV | $23,624,047 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $23,321,915 |
HTXD: Treatment: ARV Drugs | $15,328,670 |
PDTX: Treatment: Pediatric Treatment | $13,206,442 |
HLAB: Laboratory Infrastructure | $10,770,316 |
PDCS: Care: Pediatric Care and Support | $9,258,885 |
HMBL: Biomedical Prevention: Blood Safety | $5,117,678 |
HMIN: Biomedical Prevention: Injection Safety | $2,482,456 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$63,659,372
Countries/Regions
USG Aggregated Agencies:
$55,789,807
Countries/Regions
Not Available:
$52,965,905
Countries/Regions